4D pharma plc
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of MRx0518 and Avelumab in Patients With Urothelial Carcinoma (NCT05107427) | 4D pharma plc | 2022-03-01 |
| A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19 (NCT04363372) | 4D pharma plc | 2020-08-01 |
| A Study of Live Biotherapeutic Product MRx0518 With Hypofractionated Radiation Therapy in Resectable Pancreatic Cancer (NCT04193904) | 4D pharma plc | 2019-12-20 |
| A Study of MRx-4DP0004 in Asthma (NCT03851250) | 4D pharma plc | 2019-07-04 |
| Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors (NCT03637803) | 4D pharma plc | 2019-01-10 |
Track 4D pharma plc automatically
Every clearance here is in the API, with alerts when new ones post.